Medizinische Universität Graz - Research portal
Esterl Tamara |
Presentations at scientific and public conferences
Dobric, N; Suppan, C; Klocker, EV; Esterl, T; Moser, T; Hasenleithner, S; Beichler, C; Graf, R; Glawitsch, L; Weiss, L; Sandholzer, M; Steger, GG; Rinnerthaler, G; Heitzer, E; Jost, PJ; Balic, M; Dandachi, N
Pathogenic ESR1 alterations and co-alterations in HR+/HER2-advanced breast cancer
ANN ONCOL. 2025; 36: -ESMO Congress 2025; OCT 17-21, 2025; Berlin, GERMANY.
Doi: 10.1016/j.annonc.2025.08.934
[Poster]
Web of Science
FullText
FullText_MUG
Moik, F; Riedl, JM; Edlinger, L; Esterl, T; Hasenleithner, S; Kostmann, S; Cebular, L; Jahn, S; Kashofer, K; Zacharias, M; Hoefler, G; Heitzer, E; Gerger, A; Jost, PJ
Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
ANN ONCOL. 2024; 35: S262-S263.
Doi: 10.1016/j.annonc.2024.08.130
Web of Science
FullText
FullText_MUG
Moik, F; Riedl, JM; Edlinger, L; Esterl, T; Hasenleithner, S; Kostmann, S; Cebular, L; Jahn, S; Kashofer, K; Zacharias, M; Hoefler, G; Heitzer, E; Gerger, A; Jost, PJ
122P - Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
Annals of Oncology. Abstract Book of the ESMO Congress 2024, 13-17 September 2024. . 2024; 35(S2):262-263.-ESMO 2024; SEP 13-17, 2024; Barcelona, Spain.
[Poster]
FullText
Gerger, A; Riedl, J; Hasenleithner, SO; Höfler, G; Jahn, S; Esterl, T; Jost, PJ; Speicher, MR; Heitzer, E.
Identifizierung von Tumorprädispositionen im Rahmen von klinischen ctDNA-Tests
ÖGH Jahrestagung; Sep 29, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]